Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature

Kumamoto,Kensuke; Ishida,Hideyuki; Ohsawa,Tomonori; Ishibashi,Keiichiro; Ushiama,Mineko; Yoshida,Teruhiko; Iwama,Takeo

doi:10.3892/ol.2015.3578

Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature

Authors:
- Kensuke Kumamoto
- Hideyuki Ishida
- Tomonori Ohsawa
- Keiichiro Ishibashi
- Mineko Ushiama
- Teruhiko Yoshida
- Takeo Iwama
View Affiliations

Affiliations: Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama 350‑8550, Japan, Division of Genetics, National Cancer Center Research Institute, Tokyo 104‑0045, Japan
Published online on: August 6, 2015 https://doi.org/10.3892/ol.2015.3578
Pages: 2239-2243

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with familial adenomatous polyposis (FAP), which is caused by the dysfunction of the adenomatous polyposis coli (APC) protein, have the possibility of developing extracolonic manifestations, including thyroid cancer (TC), congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, and gastric and duodenal adenomas. The pathogenesis of these disorders associated with FAP is considered to be affected by the site of the germline mutation on the APC gene as a genotype‑phenotype correlation. Moreover, β‑catenin binding sites consist of 20‑amino acid repeats (20‑AARs) in the APC protein, and they are essential for the development of colorectal adenomas and certain other extracolonic manifestations. The present study retrospectively analyzed the germline and somatic mutations of the APC gene in three papillary TC patients with FAP to analyze the association between the remaining number of 20‑AARs and the development of TC. The mutation sites of two TCs did not include 20‑AARs in each allele. In one patient, the remaining number of 20‑AARs was two in the germline mutation and zero in the somatic mutation. Together with the data on 13 FAP‑associated thyroid cancerous lesions in 3 FAP patients reported previously, the majority of the remaining numbers of 20‑AARs was zero in the TC patients with FAP (13/16; 81.3%). Consequently, the APC/β‑catenin signaling pathway may be strongly involved with the pathogenesis of TC with FAP. Further accumulation of FAP patients with TC will be required to confirm the molecular pathogenesis of TC.

View Figures

View References

1	Crail HW: Multiple primary malignancies arising in the rectum, brain and thyroid; report of a case. U S Nav Med Bull. 49:123–128. 1949.PubMed/NCBI
2	Camiel MR, Mulé JE, Alexander LL and Benninghoff DL: Association of thyroid carcinoma with Gardner's syndrome in siblings. N Engl J Med. 278:1056–1058. 1968. View Article : Google Scholar : PubMed/NCBI
3	Iwama T, Mishima Y and Utsunomiya J: The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 217:101–108. 1993. View Article : Google Scholar : PubMed/NCBI
4	Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, Kelley NC and Hamilton SR: Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 34:1394–1396. 1993. View Article : Google Scholar : PubMed/NCBI
5	Plail RO, Bussey HJ, Glazer G and Thomson JP: Adenomatous polyposis: An association with carcinoma of the thyroid. Br J Surg. 74:377–380. 1987. View Article : Google Scholar : PubMed/NCBI
6	Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, Kleibeuker JH, Witjes MJ, Links TP and van Beek AP: Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol. 15:2439–2450. 2008. View Article : Google Scholar : PubMed/NCBI
7	Bertario L, Russo A, Sala P, Varesco L, Giarola M, Mondini P, Pierotti M, Spinelli P and Radice P: Hereditary colorectal tumor registry: Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol. 21:1698–1707. 2003. View Article : Google Scholar : PubMed/NCBI
8	Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, Frayling I, Efstathiou J, Pack K, Payne S, et al: The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to Knudson's ‘two-hit’ hypothesis. Nat Med. 5:1071–1075. 1999. View Article : Google Scholar : PubMed/NCBI
9	Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, Leitão CN, Fodde R and Smits R: The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet. 11:1549–1560. 2002. View Article : Google Scholar : PubMed/NCBI
10	Crabtree M, Sieber OM, Lipton L, Hodgson SV, Lamlum H, Thomas HJ, Neale K, Phillips RK, Heinimann K and Tomlinson IP: Refining the relation between ‘first hits’ and ‘second hits’ at the APC locus: The ‘loose fit’ model and evidence for differences in somatic mutation spectra among patients. Oncogene. 22:4257–4265. 2003. View Article : Google Scholar : PubMed/NCBI
11	Rubinfeld B, Albert I, Porfiri E, Munemitsu S and Polakis P: Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res. 57:4624–4630. 1997.PubMed/NCBI
12	Miyaki M, Yamaguchi T, Iijima T, Takahashi K, Matsumoto H, Yasutome M, Funata N and Mori T: Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: Variations with phenotype. Int J Cancer. 122:2491–2497. 2008. View Article : Google Scholar : PubMed/NCBI
13	Miyaki M, Iijima T, Ishii R, Hishima T, Mori T, Yoshinaga K, Takami H, Kuroki T and Iwama T: Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis. Am J Pathol. 157:1825–1827. 2000. View Article : Google Scholar : PubMed/NCBI
14	Uchino S, Noguchi S, Yamashita H, Yamashita H, Watanabe S, Ogawa T, Tsuno A, Murakami A and Miyauchi A: Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. World J Surg. 30:775–779. 2006. View Article : Google Scholar : PubMed/NCBI
15	Cetta F, Montalto G, Gori M, Curia MC, Cama A and Olschwang S: Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: Results from a European cooperative study. J Clin Endocrinol Metab. 85:286–292. 2000. View Article : Google Scholar : PubMed/NCBI
16	Septer S, Slowik V, Morgan R, Dai H and Attard T: Thyroid cancer complicating familial adenomatous polyposis: Mutation spectrum of at-risk individuals. Hered Cancer Clin Pract. 11:132013. View Article : Google Scholar : PubMed/NCBI
17	Latchford A, Volikos E, Johnson V, Rogers P, Suraweera N, Tomlinson I, Phillips R and Silver A: APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’. Hum Mol Genet. 16:78–82. 2007. View Article : Google Scholar : PubMed/NCBI
18	Cetta F, Dhamo A, Malagnino G and Barellini L: Germ-line and somatic mutations of the APC gene and/or β-catenin gene in the occurrence of FAP associated thyroid carcinoma. World J Surg. 31:1366–1367. 2007. View Article : Google Scholar : PubMed/NCBI
19	Curtis L, Wyllie AH, Shaw JJ, Williams GT, Radulescu A, DeMicco C, Haugen DR, Varhaug JE, Lillehaug JR and Wynford-Thomas D: Evidence against involvement of APC mutation in papillary thyroid carcinoma. Eur J Cancer 30A. 984–987. 1994. View Article : Google Scholar
20	Colletta G, Sciacchitano S, Palmirotta R, Ranieri A, Zanella E, Cama A, Mariani Costantini R, Battista P and Pontecorvi A: Analysis of adenomatous polyposis coli gene in thyroid tumours. Br J Cancer. 70:1085–1088. 1994. View Article : Google Scholar : PubMed/NCBI
21	Zeki K, Spambalg D, Sharifi N, Gonsky R and Fagin JA: Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms. J Clin Endocrinol Metab. 79:1317–1321. 1994. View Article : Google Scholar : PubMed/NCBI
22	Powell SM, Zilz N, BeazerBarclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B and Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature. 359:235–237. 1992. View Article : Google Scholar : PubMed/NCBI
23	Cetta F, Chiappetta G, Melillo RM, Petracci M, Montalto G, Santoro M and Fusco A: The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. J Clin Endocrinol Metab. 83:1003–1006. 1998. View Article : Google Scholar : PubMed/NCBI
24	Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, Cohen Z, Asa SL and Bapat BV: Familial adenomatous polyposis-associated thyroid cancer: A clinical, pathological and molecular genetics study. Am J Pathol. 154:127–135. 1999. View Article : Google Scholar : PubMed/NCBI
25	Romei C, Fugazzola L, Puxeddu E, Frasca F, Viola D, Muzza M, Moretti S, Nicolosi ML, Giani C, Cirello V, et al: Modifications in the papillary thyroid cancer gene profile over the last 15 years. J Clin Endocrinol Metab. 97:E1758–E1765. 2012. View Article : Google Scholar : PubMed/NCBI